chartexchange

SERA
Sera Prognostics, Inc. Class A Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:32:46 PM EST
1.86USD-2.618%(-0.05)41,876
1.4700Bid2.4800Ask1.0100Spread
Loading…
Loading…
Healthcare
Diagnostics & Research
HQ
Salt Lake City, UT, USA
Previous Close
$1.91
Beta
0.49
52-Week High
$3.85 2026-01-08
52-Week Low
$1.56 2026-05-14
SMA 50
$2.04
SMA 200
$2.06
Avg. Vol 10D
52,802
Avg. Vol 30D
32,732
Avg. Vol 90D
29,459
Relative Vol
1.28
28.02M
0.9200%
Mar 17, 2027 (118d)
Nov 16, 2026
Nov 10, 2026
Nov 6, 2026
SERA Profile

sera prognostics is a private biotechnology company developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications. sera's tests are designed to help better inform the care of a mother and her unborn child during pregnancy, and potentially lead to improved health. the company has assembled a strong management team and board of directors with significant clinical development and women's healthcare diagnostic experience. the company is supported by a strong group of investors, including the bill & melinda gates foundation, chione, ltd, domain associates, interwest partners, catalyst health ventures, upstart life sciences capital, and osage university partners. the company is working with the bill & melinda gates foundation to translate its discoveries and develop technologies to benefit women and infants in underserved countries worldwide. sera prognostics is located in salt lake city, utah. sera launched its first diagnos

SERA Performance
PeriodPriceDateChangeBeta
1W1.982026-11-12-6.06%0.781
1M2.032026-10-19-8.37%-0.032
3M1.992026-08-19-6.53%-0.170
6M1.742026-05-19+6.90%-0.040
1Y3.202025-11-19-41.88%0.490
2Y6.182024-11-19-69.90%—
5Y10.802021-11-19-82.78%0.514
SERA Stock Summary

Sera Prognostics, Inc. Class A Common Stock (NASDAQ:SERA) stock price today is $1.86, and today's volume is 41,782. SERA is down 2.618% today. The 30 day average volume is 32,732. SERA market cap is $73.97M with 39.77M shares outstanding.